Commits INR 1000 crore to Power AI-Driven Scaling, Innovation, and Strengthen HealthTech Penetration

承诺投入1000亿印度卢比，推动人工智能驱动的扩展、创新，并加强健康科技的渗透。

Lytus Technologies (OTCMKTS: LYTHF), a multinational leader in platform services and a next-generation technology-driven services company, has announced the completion of its acquisition of

Lytus Technologies（OTCMKTS：LYTHF），一家跨国平台服务领域的领导者和下一代技术驱动的服务公司，宣布已完成其收购工作。

Blod.in

Blod.in

, India’s first on-demand blood component management and logistics platform (powered by advanced AI and machine learning algorithms) – currently operational in Chennai and soon to be available nationally.

，印度首个按需血液成分管理与物流平台（由先进的人工智能和机器学习算法驱动）——目前在金奈运营，很快将在全国范围内推出。

The acquisition of Blod.in, through Lytus HealthTech, its fully owned HealthTech subsidiary, underscores Lytus’ commitment to working alongside and together with hospitals and blood banks (private and public) in efficiently serving critical healthcare needs, optimising logistics, and ultimately saving lives.

通过其全资拥有的健康科技子公司Lytus HealthTech收购Blod.in，彰显了Lytus致力于与医院和血库（包括私立和公立）携手合作，高效满足关键医疗需求、优化物流，并最终挽救生命。

This last-mile partnership fosters an extremely gratifying and supportive relationship, ensuring timely access to life-saving blood products and enhancing the overall efficiency of the healthcare ecosystem. Over the last twelve months, Blod.in scaled rapidly, growing from 30 to 140 hospitals with a 20% month-on-month growth trajectory.

这种最后一公里的合作关系促进了极为令人满意且支持性强的关系，确保及时获得挽救生命的血液制品，并提高整个医疗生态系统的效率。在过去的十二个月里，Blod.in迅速扩展，从30家医院增长到140家医院，并保持了每月20%的增长轨迹。

Now operating in Chennai, it plans to expand to 100 more hospitals and 15+ blood banks, with further growth in Bengaluru, Mumbai, and Hyderabad and other cities in the next phase. Blod.in’s AI-driven technology will soon expand to global markets like the U.S. and UAE, optimising inventory, minimizing wastage, and ensuring timely blood availability for patients, hospitals, and blood banks..

目前在金奈运营，计划扩展到100多家医院和15家以上的血库，并在下一阶段进一步扩展到班加罗尔、孟买、海得拉巴及其他城市。Blod.in的AI驱动技术将很快扩展到美国和阿联酋等全球市场，优化库存、减少浪费，并确保为患者、医院和血库提供及时的血液供应。

Significant Investments to Scale Up Operations

大规模提升运营的重要投资

Lytus Technologies has secured and committed INR 1000 crores as growth capital over the next three years to scale operations both organically and inorganically, expand its digital ecosystem, and advance HealthTech innovations. A significant portion of this investment is dedicated to advancing AI- and ML-powered solutions across Lytus HealthTech, including Blod.in’s AI engine, which optimises blood inventory forecasting, real-time supply-demand mapping, and last-mile routing intelligence for temperature-sensitive deliveries..

Lytus Technologies 已确保并承诺在未来三年内投入 1000 亿印度卢比作为增长资本，以有机和非有机方式扩大运营、拓展其数字生态系统，并推动健康科技领域的创新。这笔投资的很大一部分将用于推进 Lytus HealthTech 的人工智能和机器学习解决方案，其中包括 Blod.in 的人工智能引擎，该引擎可优化血液库存预测、实时供需映射以及针对温度敏感交付的最后一公里路线智能规划。

Mr. Dharmesh Pandya, CEO of Lytus Technologies

Lytus Technologies首席执行官Dharmesh Pandya先生

, highlighted the strategic importance of this launch in Lytus’ long-term vision. He said,

，强调了这次发布在Lytus长期愿景中的战略重要性。他表示，

“Healthcare presents a powerful intersection of business growth and societal impact. At Lytus HealthTech, we are committed to building scalable solutions that seamlessly integrate Advanced AI, ML, and Agentic AI to transform the future of blood and medical logistics. Our focus is on improving access, streamlining workflows, and delivering better patient outcomes across India.

“医疗保健是商业增长与社会影响的强大交汇点。在Lytus HealthTech，我们致力于构建可扩展的解决方案，无缝整合先进的人工智能、机器学习和代理型人工智能，以变革血液和医疗物流的未来。我们的重点是改善印度各地的医疗可及性、优化工作流程，并提供更好的患者治疗效果。

Our strong revenue trajectory reflects our ability to execute on vision and capitalize on emerging market opportunities. The INR 1000 crores financing empowers us to deepen investments in high-growth sectors while maintaining operational agility. We remain focused on sustainable growth, investing in next-generation technologies to elevate both customer experience and shareholder value”.

我们强劲的收入增长轨迹反映了我们实现愿景和抓住新兴市场机遇的能力。100亿卢比的融资使我们能够加大对高增长领域的投资，同时保持运营灵活性。我们将继续专注于可持续增长，投资于下一代技术，以提升客户体验和股东价值。

The launch of Blod.in marks a major milestone in Lytus’s strategic layering approach, enhancing stakeholder value. With a 4-million-strong existing subscriber base, Lytus is positioned to connect patients with healthcare providers, revolutionising patient care and driving HealthTech growth. At the heart of Blod.in lies a deeply collaborative and proactive approach – one that brings together hospitals, blood banks, diagnostics, and care service providers into a real-time, AI-enabled ecosystem.

Blod.in的推出标志着Lytus战略分层方法的一个重要里程碑，提升了利益相关者的价值。凭借现有的400万订阅用户基础，Lytus有望将患者与医疗服务提供者连接起来，彻底改变患者护理并推动健康科技的增长。Blod.in的核心在于其深度协作和积极主动的方法——将医院、血库、诊断机构和护理服务提供者整合到一个实时的、由人工智能驱动的生态系统中。

By co-developing protocols, integrating live data streams, and building shared dashboards, Lytus HealthTech is ensuring that every stakeholder has access to intelligent tools for faster, data-driven decision-making. Blod.in is working on and pioneering the integration of Agentic AI – autonomous digital agents capable of reasoning, decision-making, and acting without human intervention.

通过共同开发协议、整合实时数据流和构建共享仪表板，Lytus HealthTech 正在确保每位利益相关者都能获得智能工具，以实现更快速、基于数据的决策。Blod.in 正在努力并开创性地整合代理型人工智能——即可自主进行推理、决策和行动而无需人类干预的数字代理。

These intelligent agents operate across hospitals, blood banks, and logistics hubs to ensure uninterrupted, goal-driven healthcare delivery..

这些智能代理跨医院、血库和物流中心运作，以确保不间断、目标导向的医疗交付。

Following a successful pilot phase, Blod.in is set to officially launch, transforming blood logistics through its flagship platform, Blod+. The pilot proved its ability to cut blood procurement time from hours to just 90-120 minutes, addressing India’s 650,000-unit annual blood deficit, which contributes to 12,000 daily deaths..

在成功的试点阶段之后，Blod.in 即将正式推出，通过其旗舰平台 Blod+ 改变血液物流。试点项目证明了它能够将血液采购时间从数小时缩短到仅 90-120 分钟，解决印度每年 65 万单位的血液短缺问题，该短缺导致每天 12,000 人死亡。

Mr. Sai Guna Ranjan Puranam, COO of Lytus HealthTech

普拉南·赛古纳·拉詹先生，Lytus HealthTech首席运营官

, stated, “We are not just building a digital-first platform, we are building a community of healthcare providers, connected by trust, technology, and the shared mission to save lives. Our AI-first model enables proactive collaboration, not reactive firefighting — ensuring every patient, every hospital, and every unit of blood is accounted for with precision and care.

，他表示：“我们不仅仅是在构建一个数字化优先的平台，我们正在构建一个由信任、技术和共同拯救生命的使命所连接的医疗服务提供者社区。我们的 AI 优先模式实现了积极的协作，而非被动的救火——确保每一位患者、每一家医院、每一单位血液都得到精确和细致的关注。”

We are uniquely positioned to solve critical challenges in patient care and medical logistics.”.

我们有能力解决患者护理和医疗物流方面的重要挑战。